GlassScriptPhysician profile
Leah Pollifrone
NPI 1043096902
$1,406.93
in general payments reported to CMS, 2019-2025
11 companies · $1,158 in 2025
The $1,158 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $29.21 · 2024: $220 · 2025: $1,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997 · Travel and Lodging: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.81 |
| Travel and Lodging | $410.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $761.87 | 2025 | Prevena, 3m Cavilon, V.A.C. Veraflo |
| Orthofix Medical, INC. | $184.82 | 2024-2025 | Physio-Stim, Accelstim |
| Bone Support INC. | $147.36 | 2025 | Cerament G, Ceramentbone Void Filler |
| Ethicon US, LLC | $72.83 | 2025 | Dermabond Prineo, Stratafix |
| Arteriocyte Medical Systems, INC. | $59.21 | 2024-2025 | Magellan |
| Stryker Corporation | $55.09 | 2025 | Hoffmann, T2 Alpha, Pangea |
| Organogenesis INC. | $31.92 | 2025 | Puraply Wound Matrix |
| Kerecis Limited | $29.77 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $29.21 | 2023 | Prevena Restor Axioform, Prevena Restor Arthroform |
| Osteocentric Technologies, INC. | $19.41 | 2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Ferring Pharmaceuticals INC. | $15.44 | 2024 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Pollifrone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.